Advertisement

Topics

CIRCULOGENE Introduces Single-Tube, Blood-Based Microsatellite Instability (MSI) Biomarker Testing for Multiple Cancers

13:41 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
MSI Diagnostic Testing Available for Precision Cancer Immunotherapy CIRCULOGENE, a leading liquid biopsy company advancing precision medicine through personalized molecular genetics testing, has announced the availability ...

Other Sources for this Article

Media Contact
MedTech Content Marketing
Dan Snyders, 720-231-9990
Dan@MedTechContent.com
or
Company Contact
CIRCULOGENE
Scott Rezek, 205-278-1607
srezek@Circulogene.com

NEXT ARTICLE

More From BioPortfolio on "CIRCULOGENE Introduces Single-Tube, Blood-Based Microsatellite Instability (MSI) Biomarker Testing for Multiple Cancers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...